Milsaperidone and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Milsaperidone
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine and milsaperidone can affect your heart's rhythm by lengthening something called the QT interval, which is the time your heart takes to reset between beats. When two medicines that do this are taken together, the effect can add up and, in rare cases, lead to an irregular heartbeat.
I want to be clear that this concern is based on how these drugs work rather than lots of real-world reports, so please don't panic. This is very manageable. Talk with your pharmacist or doctor before combining them so your care team can decide the safest plan and keep an eye on your heart if needed.
Effect: Additive QT interval prolongation when buprenorphine and milsaperidone are combined. Both agents carry independent QT-prolonging potential, so the pharmacodynamic effect is additive rather than metabolic.
- Direction/mechanism: Additive QTc prolongation (PD interaction); neither is a prodrug in a way that alters this.
- Severity: Major. Onset: Unspecified. Evidence: Theoretical.
- Management: Manufacturer guidance advises avoiding concomitant use. If co-administration is unavoidable, consider baseline and follow-up ECG, monitor and correct electrolytes (K+, Mg2+), and review other QT-prolonging agents.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Because additive QT prolonging effects may result, milsaperidone should not be taken together with agents that prolong the QT interval1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
The documented guidance is to avoid using these two together when possible, because their QT-prolonging effects can add up.
- Keep taking both exactly as prescribed for now, and do not stop either one on your own.
- Tell your pharmacist or prescriber that you take both so they can decide whether one should be changed to an alternative.
- If your team keeps you on both, they may monitor you more closely, including checking your heart rhythm (ECG) and blood electrolytes.
- Seek care right away for fainting, palpitations, or a racing or irregular heartbeat.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Milsaperidone and Buprenorphine together?
Buprenorphine and milsaperidone can each prolong the QT interval, and using them together may add up, so guidance is to avoid the combination where possible. Check with your pharmacist or doctor before taking both. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Milsaperidone and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Milsaperidone and Buprenorphine interaction managed?
The documented guidance is to avoid using these two together when possible, because their QT-prolonging effects can add up. Keep taking both exactly as prescribed for now, and do not stop either one on your own. Tell your pharmacist or prescriber that you take both so they can decide whether one should be changed to an alternative. If your team keeps you on both, they may monitor you more closely,… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Milsaperidone or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BYSANTI™ oral tablets, milsaperidone oral tablets. Vanda Pharmaceuticals Inc. (Per Manufacturer), Washington, D.C. 2026. DailyMed
Keep reading about Buprenorphine
Keep reading about Milsaperidone
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist